Key meetings with scientists have been cancelled recently and they are uncertain about what the implications are for their research funding.
About $1.6 billion has been invested in a program that has yielded little progress, disappointing many who suffer with the complex condition.
During the pandemic, the effort suspended in-person recruiting and lost momentum.
Aside from sheer fairness issues, the racial gap could hurt patients, too.
